Monitoring of Early Changes of Circulating Tumor DNA in the Plasma of Rectal Cancer Patients Receiving Neoadjuvant Concomitant Chemoradiotherapy: Evaluation for Prognosis and Prediction of Therapeutic Response

Introduction: Patients with locally advanced rectal cancer (LARC) are undergoing neoadjuvant chemoradiotherapy (NCRT) prior to surgery. Although in some patients the NCRT is known to prevent local recurrence, it is also accompanied by side effects. Accordingly, there is an unmet need to identify pre...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Filip Pazdirek, Marek Minarik, Lucie Benesova, Tereza Halkova, Barbora Belsanova, Milan Macek, Lubomír Stepanek, Jiri Hoch
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Frontiers Media S.A. 2020-07-01
סדרה:	Frontiers in Oncology
נושאים:	rectal cancer neoadjuvant chemoradiotherapy circulating tumor ctDNA prediction prognosis response
גישה מקוונת:	https://www.frontiersin.org/article/10.3389/fonc.2020.01028/full
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!